The increasing prevalence of candidiasis is one of the primary drivers of market growth. The incidence of candidiasis has been rising steadily in recent years, primarily due to the growing use of antibiotics and immunosuppressive therapies. Antibiotics kill the beneficial bacteria in the body, which can lead to an overgrowth of the Candida fungus. Immunosuppressive therapies, such as chemotherapy and corticosteroids, weaken the immune system, making it more vulnerable to fungal infections. The increasing incidence of HIV/AIDS, diabetes, and other immunocompromising conditions also contributes to the rising prevalence of candidiasis.
The growing awareness of candidiasis and its associated health risks is another key factor driving Candidiasis Market growth. Candidiasis can cause a range of symptoms, including itching, burning, and discharge. In severe cases, it can lead to systemic infections, which can be life-threatening. As more people become aware of the risks associated with candidiasis, they are seeking treatment and prevention options. This has led to an increase in demand for antifungal medications and preventive measures.
Read more @ https://creativeedge16.blogspot.com/2023/04/candidiasis-market-global-outlook.html
